Diagnostics company quantifying cellular lipid uptake for cholesterol treatment.
| Date | Round | Amount |
|---|---|---|
| Oct 2024 | Seed MONCYTE Health raised €1M in seed funding led by Inventure, Almaral and Athensmed to advance its diagnostic technology for high cholesterol. | $1.1M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.